1. Introduction
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
2.2. Assumptions
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of End-Users
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. South America Drug Delivery Market Analysis, by Device Type
5.1. Introduction
5.2. Self-injection Devices
5.3. Conventional Devices
6. South America Drug Delivery Market Analysis, by Formulation Type
6.1. Introduction
6.2. Conventional Drug Delivery
6.3. Novel drug Delivery
7. South America Drug Delivery Market Analysis, by Therapeutic Use
7.1. Introduction
7.2. Autoimmune Disorders
7.3. Hormonal Disorders
7.4. Oncology
8. South America Drug Delivery Market Analysis, by End User
8.1. Introduction
8.2. Hospitals
8.3. Homecare settings
8.4. Research Institutes
8.5. Clinical Laboratories
9. South America Drug Delivery Market Analysis, by Country
9.1. Introduction
9.2. Mexico
9.3. Brazil
9.4. Argentina
9.5. Chile
9.6. Rest of Latin America
10. Competitive Environment and Analysis
10.1. Major Players and Strategy Analysis
10.2. Emerging Players and Market Lucrativeness
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Vendor Competitiveness Matrix
11. Company Profiles
11.1. Antares Pharma Inc.
11.2. Baxter International
11.3. Becton Dickinson Company
11.4. Elcam Medical
11.5. Unilife Corporation
11.6. West Pharmaceutical Inc.
List of Figures
List of Tables